These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 18818195)

  • 1. Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates.
    Porubsky PR; Meneely KM; Scott EE
    J Biol Chem; 2008 Nov; 283(48):33698-707. PubMed ID: 18818195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytochrome P450 2E1 structures with fatty acid analogs reveal a previously unobserved binding mode.
    Porubsky PR; Battaile KP; Scott EE
    J Biol Chem; 2010 Jul; 285(29):22282-90. PubMed ID: 20463018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform.
    Lewis DF; Bird MG; Dickins M; Lake BG; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Xenobiotica; 2000 Jan; 30(1):1-25. PubMed ID: 10659948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of the recognition of arachidonic acid by cytochrome P450 2E1 along major access tunnel.
    Cui YL; Zheng QC; Zhang JL; Zhang HX
    Biopolymers; 2015 Jan; 103(1):53-66. PubMed ID: 25257503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2E1 substrate inhibition. Mechanistic interpretation through an effector site for monocyclic compounds.
    Collom SL; Laddusaw RM; Burch AM; Kuzmic P; Perry MD; Miller GP
    J Biol Chem; 2008 Feb; 283(6):3487-3496. PubMed ID: 18056994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negatively cooperative binding properties of human cytochrome P450 2E1 with monocyclic substrates.
    Ping J; Wang YJ; Wang JF; Li X; Li YX; Hao P
    Curr Drug Metab; 2012 Sep; 13(7):1024-31. PubMed ID: 22591346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvolvement of CYP2E1 in the (omega-1)-hydroxylation of fatty acids in rat kidney microsomes.
    Amet Y; Zerilli A; Goasduff T; Dréano Y; Berthou F
    Biochem Pharmacol; 1997 Oct; 54(8):947-52. PubMed ID: 9354595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations.
    Levy JW; Hartman JH; Perry MD; Miller GP
    J Mol Graph Model; 2015 Mar; 56():43-52. PubMed ID: 25544389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alcohol-xenobiotic interactions. Role of cytochrome P450 2E1].
    Meskar A; Plee-Gautier E; Amet Y; Berthou F; Lucas D
    Pathol Biol (Paris); 2001 Nov; 49(9):696-702. PubMed ID: 11762131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling.
    Spatzenegger M; Liu H; Wang Q; Debarber A; Koop DR; Halpert JR
    J Pharmacol Exp Ther; 2003 Jan; 304(1):477-87. PubMed ID: 12490624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectral studies of tert-butyl isothiocyanate-inactivated P450 2E1.
    Kent UM; Roberts-Kirchhoff ES; Moon N; Dunham WR; Hollenberg PF
    Biochemistry; 2001 Jun; 40(24):7253-61. PubMed ID: 11401573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulations of CYP2E1.
    Li J; Wei DQ; Wang JF; Yu ZT; Chou KC
    Med Chem; 2012 Mar; 8(2):208-21. PubMed ID: 22385180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: a CO flash photolysis study.
    Smith SV; Koley AP; Dai R; Robinson RC; Leong H; Markowitz A; Friedman FK
    Biochemistry; 2000 May; 39(19):5731-7. PubMed ID: 10801323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
    Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic.
    Yang CS; Chhabra SK; Hong JY; Smith TJ
    J Nutr; 2001 Mar; 131(3s):1041S-5S. PubMed ID: 11238812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
    Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A negative cooperativity mechanism of human CYP2E1 inferred from molecular dynamics simulations and free energy calculations.
    Li J; Wei DQ; Wang JF; Li YX
    J Chem Inf Model; 2011 Dec; 51(12):3217-25. PubMed ID: 22077825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
    Yamazaki H; Shimada T
    Xenobiotica; 1999 Mar; 29(3):231-41. PubMed ID: 10219964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes: characterization of reactive intermediate adducts to the heme and apoprotein.
    Blobaum AL; Kent UM; Alworth WL; Hollenberg PF
    Chem Res Toxicol; 2002 Dec; 15(12):1561-71. PubMed ID: 12482238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism.
    Chen J; Jiang S; Wang J; Renukuntla J; Sirimulla S; Chen J
    Drug Metab Rev; 2019 May; 51(2):178-195. PubMed ID: 31203697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.